三維通信(002115.SZ):公司一貫重視自主研發 近三年累計研發投入3.49億元
格隆匯6月21日丨三維通信(002115.SZ)近期在接待機構調研時表示,公司一貫重視自主研發,近三年累計研發投入3.49億元,佔通信板塊三年累計營收的10%以上,研發人員佔公司全部人員的30%以上。研發成果方面,公司發佈的新一代5G產品先後通過了全球主流運營商等高端客户的測試和認可,已經完全能兼容滿足全球幾乎所有5G頻段,同時兼容3G/4G,是運營商解決室內網絡建設的優選解決方案。技術創新是企業持續發展的驅動力,是提升核心競爭力的關鍵,後續公司將繼續大力支持研發投入,鞏固所在細分領域專利技術的優勢地位,為全球客户提供行業內技術領先的產品解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.